Navigation Links
Gene-Eden-VIR is Most Cost Effective; polyDNA Compares Treatments for Herpes Infection
Date:4/25/2013

Rochester, NY (PRWEB) April 25, 2013

polyDNA recommends Gene-Eden-VIR as the most cost effective means of treating a latent herpes infection. During Money Smart Week (1), polyDNA is doing its part by contrasting the cost of Herpes treatments. One of those treatments is Gene-Eden-VIR, a natural remedy against the latent herpes virus.

This week, the media, government agencies, not-for-profits, schools, financial institutions and businesses of all kinds are working together to help customers manage their personal finances better. To help customers who suffer from herpes infections, polyDNA compared the cost of Valtrex, Acyclovir (Zovirax), and Gene-Eden-VIR. The first two are FDA approved medications while the third is a natural, antiviral remedy.

“I used to take Valtrex daily, but then I lost my insurance and could no longer afford a month’s supply. Taking care of my outbreaks has just been so hard since that happened. I’m looking around, constantly trying to find a way to save on herpes medications. I hate it that I have needs and I can’t afford to cover them on my own.” – Jenna R.

According to herpesnews.com, the cost of a month’s supply of Valtrex (90 pills), one of the most common anti-herpes medications, is $1275 for the brand name at the CVS Pharmacy. (2) The cost of the generic brand is only slightly less.

While Acyclovir (Zovirax) is significantly cheaper, this herpes medication still costs at least $140.00 for 90 pills. (2)

Gene-Eden-VIR is an antiviral remedy that boosts the immune system against the latent herpes viruses. A month’s supply of Gene-Eden-VIR is $37.99. That’s $102.01 cheaper than Zovirax, and well over $1,000 cheaper than Valtrex.

In a post marketing clinical study, Gene-Eden-VIR was shown to be safe and highly effective against the latent herpes viruses. Over 70% of Gene-Eden-VIR users reported a reduction in herpes symptoms. (3)

Gene-Eden-VIR is
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome
2. Study Says Kidney Bean Leaves Work Against Bed Bugs, My Cleaning Products Compares Its With a Non-Pesticide Bed Bug Spray
3. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
4. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
5. Atlanta LASIK Surgeon Dr. Ashraf Releases YouTube Videos Featuring Patient Testimonials and Discussion of Common Eye Treatments
6. Lung Cancer Survivors Share Stories of Value of Early Detection and Hope for More Effective Treatments
7. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
8. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
9. Bacterias hidden skill could pave way for stem cell treatments
10. Find New Cancer Treatments at cureLauncher
11. American Heart Month: Find New Heart Disease Treatments on cureLauncher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015  El ... abre hoy su llamada a nominaciones para 2015. Este ... ha hecho, o tiene el potencial para hacer, contribuciones ... nominaciones se aceptarán hasta el 15 de marzo de ...
(Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), today announced ... on May 4, 2015 (the "Annual Meeting"). Because ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... Inc. (OTC Bulletin Board: PDAE) today announced that its ... relief under Chapter 11 of the United States Bankruptcy ... Northern District of Texas. The company intends to sell ... a Section 363 sale process approved by the bankruptcy ...
... Intercell AG,(VSE: ICLL) today announced that the Australian ... company,s vaccine to,prevent Japanese Encephalitis. This final decision ... provided by Australian Drug Evaluation,Committee (ADEC) in December ... of the Australian authorities represents the first,regulatory approval ...
... Aerolase Corporation, a leading manufacturer of next-generation ... that sales increased dramatically in 2008 over 2007. ... laser market helped to more than offset current ... a record sales month for Aerolase, and 2008 ...
Cached Biology Technology:Panda Ethanol's Hereford, Texas Subsidiary Files Voluntary Chapter 11 2Panda Ethanol's Hereford, Texas Subsidiary Files Voluntary Chapter 11 3Australian Authorities (TGA) First to Grant Final Product Approval for Intercell's Vaccine to Prevent Japanese Encephalitis 2Australian Authorities (TGA) First to Grant Final Product Approval for Intercell's Vaccine to Prevent Japanese Encephalitis 3Australian Authorities (TGA) First to Grant Final Product Approval for Intercell's Vaccine to Prevent Japanese Encephalitis 4Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 2Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 3
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced ... Perimeter Security Systems Market" report to their offering. ... American perimeter security market is estimated to grow at a ... market holds a larger share in this market, ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has ... - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally different ... the first time a fingerprint sensor in its product. ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... blood and marrow transplant physician Naynesh Kamani, ... a new national clinical trial of unrelated donor marrow ... sickle cell disease . Children,s National will join more ... II clinical trial of this treatment. If successful, the ...
... the "air pollution danger zone," according to new research ... researchers have found that more than 30 percent of ... quarter mile, of major highways that consistently serve as ... shown that proximity to major highwaysand thus environmental pollutants, ...
... bees industriously bring pollen and nectar to the hive, ... of pesticides, according to Penn State researchers. Add the ... structure of the hive, and bee researchers see a ... approach may mitigate at least some beeswax contamination. ...
Cached Biology News:Children's national co-leads nationwide study of landmark sickle cell treatment 2Many US public schools in 'air pollution danger zone' 2Many US public schools in 'air pollution danger zone' 3Pesticide build-up could lead to poor honey bee health 2Pesticide build-up could lead to poor honey bee health 3Pesticide build-up could lead to poor honey bee health 4
Recombinant Mouse MMP-9, CF...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
... for 10 L sample. Ideal for small volume applications, including pediatric, neonatal, geriatric, general adult, veterinary ... less than 3 minutes after turn-on. ... ... ...
Biology Products: